Sionna Therapeutics (SION) Income from Continuing Operations (2024 - 2026)
Sionna Therapeutics (SION) posted Income from Continuing Operations of 26779000.0 for Q1 2026, up 85.79% sequentially from 188447000.0 in Q4 2025, and down 60.75% YoY from 68223178.01 in Q1 2025.
Sionna Therapeutics (SION) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Income from Continuing Operations for 3 years, with the latest figure at 26779000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 60.75% year-over-year to 26779000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 253814000.0 (down 113.94% YoY) and the FY2025 annual result came in at 243694000.0, down 113.78% from the prior year.
- Income from Continuing Operations advanced to 26779000.0 in Q1 2026 per SION's latest filing, from 188447000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 8726000.0 in Q2 2024 and troughed at 188447000.0 in Q4 2025.
- A 3-year average of 42718333.33 and a median of 20349000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 20.61% in 2025, down 178.69% in 2025.
- Over 3 years, Income from Continuing Operations stood at 67620000.0 in 2024, then sank by 178.69% to 188447000.0 in 2025, then surged by 85.79% to 26779000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 26779000.0, 188447000.0, and 20349000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,096.02 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | -29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.88 Mn |
| Mar 31, 2026 | -26.78 Mn |
| Dec 31, 2025 | -188.45 Mn |
| Sep 30, 2025 | -20.35 Mn |
| Jun 30, 2025 | -18.24 Mn |
| Mar 31, 2025 | -16.66 Mn |
| Dec 31, 2024 | -67.62 Mn |
| Sep 30, 2024 | -25.63 Mn |
| Jun 30, 2024 | -8.73 Mn |
| Mar 31, 2024 | -12.02 Mn |